Cancer Center in Boston to Sell $115M of Debt

Piazza, Johanna
April 2004
Bond Buyer;4/29/2004, Vol. 348 Issue 31873, p4
Trade Publication
Reports on cancer research facility, Dana Farber Cancer Institute in Boston, Massachusetts' sale of auction-rate revenue bonds. Series of bonds to be sold; Transactions handled by Goldman Sachs & Co. and Fleet Bank; Issuance of additional Series H-3 taxable bonds as periodic auction reset securities.


Related Articles

  • MassHEFA to Sell $214 Million for Two Cancer Facilities. Kaske, Michelle // Bond Buyer;1/17/2007, Vol. 359 Issue 32548, p36 

    The article reports on the plan of the Massachusetts Health and Educational Facilities Authority to issue 214 million of bonds on behalf of two hospitals to finance cancer-treatment facilities in the Boston, Massachusetts area. 150 million dollars will be given to the Dana-Farber Cancer...

  • State probe shows Dana-Farber failed to follow basic protocols. Morrissey, John // Modern Healthcare;6/19/95, Vol. 25 Issue 25, p82 

    Reports on the Massachusetts Department of Public Health's investigation of Dana-Farber Cancer Institute's basic protocols for a potent experimental chemotherapy. Death and serious injuries of patients due mistakes in the administration of dosages; Pharmacists and nurses' errors; Investigation...

  • State investigators cite cancer center's errors.  // Modern Healthcare;6/5/95, Vol. 25 Issue 23, p24 

    Reports on the findings of a state investigation on Dana-Farber Cancer Institute in Boston, Mass. in relation to the pattern of errors committed by the hospital staff and medical personnel. Death of a patient and severe heart damage due to chemotherapy; Resignation of hospital personnel after...

  • Dana-Farber cleared for Medicare funds.  // Modern Healthcare;8/7/95, Vol. 25 Issue 32, p6 

    Reports the continuation of Medicare funds to the Dana-Farber Cancer Institute in Boston which was earlier canceled due to the death of a patient. Clearance from HCFA; Note on the death case.

  • Three Boston hospitals agree to combine cancer programs. Morrissey, John // Modern Healthcare;1/22/96, Vol. 26 Issue 4, p16 

    Reports that Boston, Massachusetts-based Dana-Farber Cancer Institute, Massachusetts General Hospital and Brigham & Women's Hospital has agreed to combine cancer programs. Terms of the partnership agreement; Expected benefits on the merger of the programs; Comments from B.D. Colen, a...

  • In case you haven't heard...  // Primary Care Weekly;7/22/96, Vol. 2 Issue 29, p8 

    Reports on Boston, Massachusetts-based Dana-Farber Cancer Institute's recommendation that policymakers not move hastily toward doctor-assisted suicide in the United States.

  • A mess at the best. Brink, Susan // U.S. News & World Report;6/12/95, Vol. 118 Issue 23, p10 

    Focuses on an investigation of the Dana-Farber Cancer Institute in Boston, Massachusetts. Report which outlined dozens of errors at the cancer center, including the absence of an adequate quality-assurance system to catch patterns of errors before they become terrible mistakes; Instances in...

  • Elite cancer center gave journalist fatal drug dose.  // Modern Healthcare;3/27/95, Vol. 25 Issue 13, p9 

    Reports on the death of health columnist Betsy Lehman of a mistaken drug dose at the Dana-Farber Cancer Institute in Boston, Massachusetts. Impact on the reputation of American hospitals; Comments from David M. Livingston, Dana-Farber's physician-in-chief.

  • Cancer center's bonds unaffected by uproar. Pallarito, Karen // Modern Healthcare;4/3/95, Vol. 25 Issue 14, p14 

    Reports on the impact of a chemotherapy overdose of a Dana-Farber Cancer Institute patient on the sale of the center's bonds. Details on the death of the patient, Betsy Lehman; Response of investors; Measures to determine a bond issuer's creditworthiness.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics